Table 1.
No. | G‐CSF derivative | Dose of G‐CSF (μg/kg) | Timing of G‐CSF | CP administration |
---|---|---|---|---|
1 (control group) | Vehicle | – | Same day | Yes |
2 (control group) | Vehicle | – | Next day | Yes |
3 | Maxy‐G34 | 30 | Same day | Yes |
4 | Maxy‐G34 | 100 | Same day | Yes |
5 | Maxy‐G34 | 300 | Same day | Yes |
6 | Maxy‐G34 | 30 | Next day | Yes |
7 | Maxy‐G34 | 100 | Next day | Yes |
8 | Maxy‐G34 | 100 | – | No |
9 | Maxy‐G34 | 300 | – | No |
10 | Maxy‐G34 | 1000 | – | No |
11 | Pegfilgrastim | 100 | Same day | Yes |
12 | Pegfilgrastim | 300 | Same day | Yes |
13 | Pegfilgrastim | 1000 | Same day | Yes |
14 | Pegfilgrastim | 100 | Next day | Yes |
CP, cyclophosphamide; G‐CSF, granulocyte colony‐stimulating factor.